explore -WSS

explore

author：knowledge 2025-10-04 04:01:20 - browse：85

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Stop the failed accountable care organization experiment

Wikipedia

WSS

Neuroscience’s long legacy of racism

Welsh Carson private equity firm escapes from FTC antitrust case

Primary care doctor shortage won't be solved by free med school tuition

Stop the failed accountable care organization experiment

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Gene editing the human germline: What are the risks?

leisure time

explore

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Brain technologies pose threats that are all too real, experts warn

United colonoscopy coverage change 'may cost lives,' doctors say

Brain MRIs reveal impact of 'toxic stress' on Black children

Tori Bowie and the unacceptable rates of Black maternal death

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Drug repurposing or repositioning? The language matters

Colonoscopy prep: Liquid

Jerome Adams on the need for new antivirals for Covid

GSK’s asthma push continues as drug succeeds in Phase 3 trials

explore

Virtual Event: March of the Biosimilars

Most antidepressants don't work on kids, teens, study finds

Argenx readies a blockbuster opportunity with drug for autoimmune disease

AltruBio raises $225 million to develop ulcerative colitis drug

Brain technologies pose threats that are all too real, experts warn

Novel spinal cord stimulator treats paralysis without surgery

entertainment

hotspot

Wikipedia

explore